Published in Thromb Haemost on May 01, 1998
Testosterone supplementation in male obese Zucker rats reduces body weight and improves insulin sensitivity but increases blood pressure. Hypertension (2012) 1.59
Genome-wide association analysis of oxidative stress resistance in Drosophila melanogaster. PLoS One (2012) 1.14
Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol (2008) 1.08
Sex and gender differences in control of blood pressure. Clin Sci (Lond) (2013) 1.08
Hypertension in postmenopausal women. Curr Hypertens Rep (2012) 1.07
Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. Am J Physiol Heart Circ Physiol (2008) 0.92
Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). Virchows Arch (2013) 0.80
A single pill to treat postmenopausal hypertension? Not yet. Curr Top Med Chem (2011) 0.79
Renal phenotype of ET-1 transgenic mice is modulated by androgens. Eur J Med Res (2009) 0.77
Orchidectomy enhances the expression of endothelin-1 and ETB receptors in rat portal vein. J Smooth Muscle Res (2014) 0.77
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol (1999) 7.15
Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia (1999) 3.60
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
Monoclonal antibody PAL-E specific for endothelium. Lab Invest (1985) 2.37
Effect of homocysteine-lowering treatment with folic acid plus vitamin B6 on progression of subclinical atherosclerosis: a randomised, placebo-controlled trial. Lancet (2000) 2.26
Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15
The influence of improved glycaemic control with insulin and sulphonylureas on acute phase and endothelial markers in Type II diabetic subjects. Diabetologia (2000) 2.14
The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell (2000) 2.12
Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol (1998) 2.09
Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res (1999) 2.00
Comparison of seven immunoassays for the quantification of CA 125 antigen in serum. Clin Chem (1998) 1.90
Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) (1997) 1.90
[Clinical judgment and decision in practice. A patient with dyspnea]. Ned Tijdschr Geneeskd (1996) 1.71
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol (2005) 1.70
ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: the EURODIAB Study. J Intern Med (2009) 1.68
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia (1999) 1.67
Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. J Exp Med (1986) 1.64
Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol (1997) 1.62
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology (2001) 1.57
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55
Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries. Cardiovasc Res (1999) 1.54
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck. J Nucl Med (2000) 1.52
Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51
Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia (2008) 1.48
[Periodic fever due to hyper-IgD syndrome]. Ned Tijdschr Geneeskd (2000) 1.48
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46
Key priorities in managing glucose control in older people with diabetes. J Nutr Health Aging (2009) 1.45
Analysis of twenty-four-hour ambulatory blood pressure monitoring: what time period to assess blood pressures during waking and sleeping? J Hypertens (1995) 1.44
Endothelial dysfunction: cause of the insulin resistance syndrome. Diabetes (1997) 1.44
Birth order and sibling sex ratio in two samples of Dutch gender-dysphoric homosexual males. Arch Sex Behav (1996) 1.43
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol (1998) 1.42
Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation (1999) 1.42
Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest (2000) 1.41
Influence of sex hormones on plasma endothelin levels. Ann Intern Med (1993) 1.40
[Primary hyperaldosteronism as a cause of hypertension; diagnosis]. Ned Tijdschr Geneeskd (1996) 1.40
Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clin Endocrinol (Oxf) (1995) 1.40
[Clinical judgment and decision making in clinical practice. A patient with fever and neck pain]. Ned Tijdschr Geneeskd (1996) 1.39
An epidemiological and demographic study of transsexuals in The Netherlands. Arch Sex Behav (1996) 1.38
Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP). J Thromb Haemost (2003) 1.37
Effects of monocytopenia and anticoagulation in experimental Streptococcus sanguis endocarditis. Br J Exp Pathol (1980) 1.36
Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood (1988) 1.34
Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium. Blood (1985) 1.33
Inhibition of tissue-type plasminogen activator by conditioned medium from cultured human and porcine vascular endothelial cells. Biochem Biophys Res Commun (1983) 1.32
Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl) (1998) 1.31
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl (2008) 1.31
Comparison of blood pressure measurement methods. Lancet (1997) 1.29
Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab (1994) 1.28
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. J Androl (2006) 1.26
Fluid endocytosis by rat liver and spleen. Experiments with 125I-labelled poly(vinylpyrrolidone) in vivo. Biochem J (1980) 1.26
Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost (1987) 1.25
Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. Biochem J (1995) 1.25
Markers of inflammation and cellular adhesion molecules in relation to insulin resistance in nondiabetic elderly: the Rotterdam study. J Clin Endocrinol Metab (2001) 1.25
Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem (1990) 1.24
Endocytosis and breakdown of 125I-labelled lactate dehydrogenase isoenzyme M4 by rat liver and spleen in vivo. Biochem J (1979) 1.23
ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res (2008) 1.22
Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol (1999) 1.21
Human plasminogen activator inhibitor-1 gene. Promoter and structural gene nucleotide sequences. J Biol Chem (1988) 1.21
Pathogenesis of postoperative adhesion formation. Br J Surg (2011) 1.18
Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem (2001) 1.17
Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism (2004) 1.17
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2. J Lab Clin Med (1985) 1.17
Production of plasminogen activators and inhibitor by serially propagated endothelial cells from adult human blood vessels. Arteriosclerosis (1987) 1.16
Use of fibrinolytic agents in the prevention of postoperative adhesion formation. Fertil Steril (2000) 1.15
Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells. J Biol Chem (1991) 1.15
Endocytosis and breakdown of ribonuclease oligomers by sinusoidal rat liver cells in vivo. I. Effect of size. Biochim Biophys Acta (1979) 1.15
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides. Int J Cancer (2000) 1.15
In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab (2000) 1.14
Increased plasma homocysteine after menopause. Atherosclerosis (2000) 1.14
The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study. Diabetes Care (1998) 1.14
The prevalence of transsexualism in The Netherlands. Acta Psychiatr Scand (1993) 1.13
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13
Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction. Hypertension (2001) 1.13
APOE-epsilon4 is associated with memory decline in cognitively impaired elderly. Neurology (2000) 1.12
Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler Thromb Vasc Biol (1997) 1.11
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur J Cancer (1996) 1.11
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium. Biochim Biophys Acta (1984) 1.11
[Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant]. Ned Tijdschr Geneeskd (2000) 1.10
Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology (1991) 1.10
Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease. Diabetes Metab (2005) 1.10